Unknown

Dataset Information

0

Evaluation of Vaccine Strains Developed for Efficient, Broad-Range Protection against Foot-and-Mouth Disease Type O.


ABSTRACT: Foot-and-mouth disease (FMD) type O includes 11 genetic topotypes. The Southeast Asia (SEA), Middle East-South Asia (ME-SA), and Cathay topotypes belong to FMD type O and occur frequently in Asia. Therefore, it is necessary to develop a potent vaccine strain with a broad antigenic coverage in order to provide complete protection against these three topotypes. In this study, an experimental vaccine was produced using chimeric vaccine strains (JC-VP1 or PA2-VP1) that contained VP4, VP2, and VP3 of the ME-SA topotype (O Manisa) and VP1 of the SEA topotype (Mya98 lineage; O/SKR/Jincheon/2014) or ME-SA topotype (PanAsia2 lineage; O/PAK/44). Mice were immunized with the experimental vaccines, and they were fully protected against the three topotypes. The neutralizing antibody titers of PA2-VP1 were significantly higher than those of JC-VP1 in the early vaccination phase in pigs. Here, we confirmed complete protection in pigs vaccinated with JC-VP1 or PA2-VP1, when challenged against the SEA (O/SKR/Jincheon/2014), ME-SA (O/SKR/Boeun/2017) and Cathay (O/Taiwan/97) topotype viruses, with moderately higher protection provided by PA2-VP1 than by JC-VP1.

SUBMITTER: Hwang SY 

PROVIDER: S-EPMC9963059 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Evaluation of Vaccine Strains Developed for Efficient, Broad-Range Protection against Foot-and-Mouth Disease Type O.

Hwang Seong Yun SY   Shin Sung Ho SH   Kim Hyun Mi HM   Shin SeHee S   Lee Min Ja MJ   Kim Su-Mi SM   Lee Jong-Soo JS   Park Jong-Hyeon JH  

Vaccines 20230127 2


Foot-and-mouth disease (FMD) type O includes 11 genetic topotypes. The Southeast Asia (SEA), Middle East-South Asia (ME-SA), and Cathay topotypes belong to FMD type O and occur frequently in Asia. Therefore, it is necessary to develop a potent vaccine strain with a broad antigenic coverage in order to provide complete protection against these three topotypes. In this study, an experimental vaccine was produced using chimeric vaccine strains (JC-VP1 or PA2-VP1) that contained VP4, VP2, and VP3 of  ...[more]

Similar Datasets

| S-EPMC10819240 | biostudies-literature
| S-EPMC9751447 | biostudies-literature
| S-EPMC5964523 | biostudies-literature
| S-EPMC10142530 | biostudies-literature
| S-EPMC7107087 | biostudies-literature
| S-EPMC7411152 | biostudies-literature
| S-EPMC11209096 | biostudies-literature
| S-EPMC7157218 | biostudies-literature
| S-EPMC9960313 | biostudies-literature
| S-EPMC7854682 | biostudies-literature